nodes	percent_of_prediction	percent_of_DWPC	metapath
Gliclazide—ABCC8—type 2 diabetes mellitus	0.0654	0.417	CbGaD
Gliclazide—Glimepiride—type 2 diabetes mellitus	0.0604	0.185	CrCtD
Gliclazide—Tolazamide—type 2 diabetes mellitus	0.0604	0.185	CrCtD
Gliclazide—Glipizide—type 2 diabetes mellitus	0.0573	0.175	CrCtD
Gliclazide—Tolbutamide—type 2 diabetes mellitus	0.0573	0.175	CrCtD
Gliclazide—Chlorpropamide—type 2 diabetes mellitus	0.0524	0.16	CrCtD
Gliclazide—KCNJ11—type 2 diabetes mellitus	0.0461	0.294	CbGaD
Gliclazide—Glyburide—type 2 diabetes mellitus	0.0397	0.121	CrCtD
Gliclazide—VEGFA—type 2 diabetes mellitus	0.0357	0.228	CbGaD
Gliclazide—ABCC8—Tolazamide—type 2 diabetes mellitus	0.0181	0.0851	CbGbCtD
Gliclazide—ABCC8—Glimepiride—type 2 diabetes mellitus	0.0162	0.0759	CbGbCtD
Gliclazide—KCNJ11—Tolazamide—type 2 diabetes mellitus	0.0157	0.0736	CbGbCtD
Gliclazide—ABCC8—Glipizide—type 2 diabetes mellitus	0.0148	0.0694	CbGbCtD
Gliclazide—KCNJ11—Glimepiride—type 2 diabetes mellitus	0.014	0.0656	CbGbCtD
Gliclazide—ABCC8—Repaglinide—type 2 diabetes mellitus	0.0129	0.0607	CbGbCtD
Gliclazide—KCNJ11—Glipizide—type 2 diabetes mellitus	0.0128	0.06	CbGbCtD
Gliclazide—ABCC8—Chlorpropamide—type 2 diabetes mellitus	0.0117	0.0549	CbGbCtD
Gliclazide—KCNJ11—Repaglinide—type 2 diabetes mellitus	0.0112	0.0524	CbGbCtD
Gliclazide—ABCC8—Tolbutamide—type 2 diabetes mellitus	0.0104	0.0489	CbGbCtD
Gliclazide—KCNJ11—Chlorpropamide—type 2 diabetes mellitus	0.0101	0.0474	CbGbCtD
Gliclazide—ALB—type 2 diabetes mellitus	0.0096	0.0612	CbGaD
Gliclazide—KCNJ11—Tolbutamide—type 2 diabetes mellitus	0.009	0.0423	CbGbCtD
Gliclazide—ABCC8—Nateglinide—type 2 diabetes mellitus	0.00886	0.0416	CbGbCtD
Gliclazide—Glimepiride—Tolbutamide—type 2 diabetes mellitus	0.00778	0.0365	CrCrCtD
Gliclazide—Glimepiride—Glipizide—type 2 diabetes mellitus	0.00778	0.0365	CrCrCtD
Gliclazide—Tolazamide—Tolbutamide—type 2 diabetes mellitus	0.00778	0.0365	CrCrCtD
Gliclazide—Tolazamide—Glipizide—type 2 diabetes mellitus	0.00778	0.0365	CrCrCtD
Gliclazide—KCNJ11—Nateglinide—type 2 diabetes mellitus	0.00766	0.0359	CbGbCtD
Gliclazide—Glipizide—Tolazamide—type 2 diabetes mellitus	0.00737	0.0346	CrCrCtD
Gliclazide—Tolbutamide—Glimepiride—type 2 diabetes mellitus	0.00737	0.0346	CrCrCtD
Gliclazide—Glipizide—Glimepiride—type 2 diabetes mellitus	0.00737	0.0346	CrCrCtD
Gliclazide—Tolbutamide—Tolazamide—type 2 diabetes mellitus	0.00737	0.0346	CrCrCtD
Gliclazide—Glimepiride—Chlorpropamide—type 2 diabetes mellitus	0.00711	0.0334	CrCrCtD
Gliclazide—Tolazamide—Chlorpropamide—type 2 diabetes mellitus	0.00711	0.0334	CrCrCtD
Gliclazide—Tolbutamide—Glipizide—type 2 diabetes mellitus	0.00699	0.0328	CrCrCtD
Gliclazide—Glipizide—Tolbutamide—type 2 diabetes mellitus	0.00699	0.0328	CrCrCtD
Gliclazide—Glisoxepide—Glimepiride—type 2 diabetes mellitus	0.00671	0.0315	CrCrCtD
Gliclazide—Glisoxepide—Tolazamide—type 2 diabetes mellitus	0.00671	0.0315	CrCrCtD
Gliclazide—Glipizide—Chlorpropamide—type 2 diabetes mellitus	0.00639	0.03	CrCrCtD
Gliclazide—Tolbutamide—Chlorpropamide—type 2 diabetes mellitus	0.00639	0.03	CrCrCtD
Gliclazide—Glisoxepide—Glipizide—type 2 diabetes mellitus	0.00636	0.0299	CrCrCtD
Gliclazide—Glisoxepide—Tolbutamide—type 2 diabetes mellitus	0.00636	0.0299	CrCrCtD
Gliclazide—Glyburide—Glimepiride—type 2 diabetes mellitus	0.00617	0.0289	CrCrCtD
Gliclazide—Glyburide—Tolazamide—type 2 diabetes mellitus	0.00617	0.0289	CrCrCtD
Gliclazide—Chlorpropamide—Tolazamide—type 2 diabetes mellitus	0.00617	0.0289	CrCrCtD
Gliclazide—Chlorpropamide—Glimepiride—type 2 diabetes mellitus	0.00617	0.0289	CrCrCtD
Gliclazide—ABCC8—Glyburide—type 2 diabetes mellitus	0.00598	0.0281	CbGbCtD
Gliclazide—Glyburide—Glipizide—type 2 diabetes mellitus	0.00585	0.0274	CrCrCtD
Gliclazide—Chlorpropamide—Tolbutamide—type 2 diabetes mellitus	0.00585	0.0274	CrCrCtD
Gliclazide—Chlorpropamide—Glipizide—type 2 diabetes mellitus	0.00585	0.0274	CrCrCtD
Gliclazide—Glisoxepide—Chlorpropamide—type 2 diabetes mellitus	0.00582	0.0273	CrCrCtD
Gliclazide—Tolazamide—Glyburide—type 2 diabetes mellitus	0.00539	0.0253	CrCrCtD
Gliclazide—Glimepiride—Glyburide—type 2 diabetes mellitus	0.00539	0.0253	CrCrCtD
Gliclazide—Glyburide—Chlorpropamide—type 2 diabetes mellitus	0.00535	0.0251	CrCrCtD
Gliclazide—KCNJ11—Glyburide—type 2 diabetes mellitus	0.00517	0.0243	CbGbCtD
Gliclazide—Glipizide—Glyburide—type 2 diabetes mellitus	0.00484	0.0227	CrCrCtD
Gliclazide—Glisoxepide—Glyburide—type 2 diabetes mellitus	0.00441	0.0207	CrCrCtD
Gliclazide—Chlorpropamide—Glyburide—type 2 diabetes mellitus	0.00405	0.019	CrCrCtD
Gliclazide—Sulfacetamide—Tolazamide—type 2 diabetes mellitus	0.00279	0.0131	CrCrCtD
Gliclazide—Sulfacetamide—Tolbutamide—type 2 diabetes mellitus	0.00264	0.0124	CrCrCtD
Gliclazide—ALB—Repaglinide—type 2 diabetes mellitus	0.00243	0.0114	CbGbCtD
Gliclazide—Sulfacetamide—Chlorpropamide—type 2 diabetes mellitus	0.00242	0.0113	CrCrCtD
Gliclazide—ALB—Rosiglitazone—type 2 diabetes mellitus	0.00203	0.00953	CbGbCtD
Gliclazide—ALB—Valsartan—type 2 diabetes mellitus	0.00179	0.00842	CbGbCtD
Gliclazide—ALB—Nateglinide—type 2 diabetes mellitus	0.00167	0.00783	CbGbCtD
Gliclazide—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.00164	0.0077	CbGbCtD
Gliclazide—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0015	0.00704	CbGbCtD
Gliclazide—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.00143	0.00669	CbGbCtD
Gliclazide—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.00143	0.00669	CbGbCtD
Gliclazide—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.00132	0.00618	CbGbCtD
Gliclazide—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.00127	0.00597	CbGbCtD
Gliclazide—ABCC8—penis—type 2 diabetes mellitus	0.00125	0.252	CbGeAlD
Gliclazide—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00119	0.00557	CbGbCtD
Gliclazide—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00119	0.00557	CbGbCtD
Gliclazide—ALB—Glyburide—type 2 diabetes mellitus	0.00113	0.00529	CbGbCtD
Gliclazide—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00109	0.00514	CbGbCtD
Gliclazide—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00106	0.00496	CbGbCtD
Gliclazide—ALB—Losartan—type 2 diabetes mellitus	0.00103	0.00483	CbGbCtD
Gliclazide—CYP2C9—Valsartan—type 2 diabetes mellitus	0.000967	0.00454	CbGbCtD
Gliclazide—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.000899	0.00422	CbGbCtD
Gliclazide—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.000862	0.00404	CbGbCtD
Gliclazide—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00073	0.00343	CbGbCtD
Gliclazide—CYP2C19—Losartan—type 2 diabetes mellitus	0.000668	0.00313	CbGbCtD
Gliclazide—CYP2C9—Glyburide—type 2 diabetes mellitus	0.000607	0.00285	CbGbCtD
Gliclazide—CYP2C9—Losartan—type 2 diabetes mellitus	0.000555	0.00261	CbGbCtD
Gliclazide—VEGFA—islet of Langerhans—type 2 diabetes mellitus	0.00042	0.0849	CbGeAlD
Gliclazide—VEGFA—nephron tubule—type 2 diabetes mellitus	0.000339	0.0684	CbGeAlD
Gliclazide—KCNJ11—islet of Langerhans—type 2 diabetes mellitus	0.000301	0.0608	CbGeAlD
Gliclazide—VEGFA—pancreas—type 2 diabetes mellitus	0.000296	0.0597	CbGeAlD
Gliclazide—VEGFA—cortex of kidney—type 2 diabetes mellitus	0.00029	0.0585	CbGeAlD
Gliclazide—ABCC8—islet of Langerhans—type 2 diabetes mellitus	0.000277	0.056	CbGeAlD
Gliclazide—VEGFA—adipose tissue—type 2 diabetes mellitus	0.000268	0.0542	CbGeAlD
Gliclazide—KCNJ11—cardiovascular system—type 2 diabetes mellitus	0.000217	0.0439	CbGeAlD
Gliclazide—KCNJ11—pancreas—type 2 diabetes mellitus	0.000211	0.0427	CbGeAlD
Gliclazide—ABCC8—cardiovascular system—type 2 diabetes mellitus	0.0002	0.0405	CbGeAlD
Gliclazide—ABCC8—kidney—type 2 diabetes mellitus	0.000196	0.0396	CbGeAlD
Gliclazide—ABCC8—pancreas—type 2 diabetes mellitus	0.000195	0.0393	CbGeAlD
Gliclazide—VEGFA—liver—type 2 diabetes mellitus	0.000188	0.038	CbGeAlD
Gliclazide—VEGFA—Glyburide—Glimepiride—type 2 diabetes mellitus	0.000178	0.203	CbGdCrCtD
Gliclazide—VEGFA—Glyburide—Tolazamide—type 2 diabetes mellitus	0.000178	0.203	CbGdCrCtD
Gliclazide—VEGFA—Glyburide—Glipizide—type 2 diabetes mellitus	0.000168	0.192	CbGdCrCtD
Gliclazide—VEGFA—Glyburide—Chlorpropamide—type 2 diabetes mellitus	0.000154	0.176	CbGdCrCtD
Gliclazide—Tolazamide—ABCC8—type 2 diabetes mellitus	0.000153	0.102	CrCbGaD
Gliclazide—Glisoxepide—ABCC8—type 2 diabetes mellitus	0.000138	0.0918	CrCbGaD
Gliclazide—Glimepiride—ABCC8—type 2 diabetes mellitus	0.000136	0.0905	CrCbGaD
Gliclazide—VEGFA—Enalapril—Nateglinide—type 2 diabetes mellitus	0.000123	0.14	CbGdCrCtD
Gliclazide—Glipizide—ABCC8—type 2 diabetes mellitus	0.000118	0.0785	CrCbGaD
Gliclazide—Tolazamide—KCNJ11—type 2 diabetes mellitus	0.000108	0.0716	CrCbGaD
Gliclazide—Glisoxepide—KCNJ11—type 2 diabetes mellitus	9.72e-05	0.0647	CrCbGaD
Gliclazide—Glimepiride—KCNJ11—type 2 diabetes mellitus	9.58e-05	0.0638	CrCbGaD
Gliclazide—CYP2C9—cardiovascular system—type 2 diabetes mellitus	8.95e-05	0.0181	CbGeAlD
Gliclazide—ALB—liver—type 2 diabetes mellitus	8.87e-05	0.0179	CbGeAlD
Gliclazide—Chlorpropamide—ABCC8—type 2 diabetes mellitus	8.53e-05	0.0567	CrCbGaD
Gliclazide—Tolbutamide—ABCC8—type 2 diabetes mellitus	8.31e-05	0.0553	CrCbGaD
Gliclazide—Glyburide—CPT1A—type 2 diabetes mellitus	8.31e-05	0.0553	CrCbGaD
Gliclazide—Glipizide—KCNJ11—type 2 diabetes mellitus	8.31e-05	0.0553	CrCbGaD
Gliclazide—VEGFA—Enalapril—Ramipril—type 2 diabetes mellitus	7.47e-05	0.0853	CbGdCrCtD
Gliclazide—CYP2C19—liver—type 2 diabetes mellitus	7.14e-05	0.0144	CbGeAlD
Gliclazide—Chlorpropamide—KCNJ11—type 2 diabetes mellitus	6.01e-05	0.04	CrCbGaD
Gliclazide—Tolbutamide—KCNJ11—type 2 diabetes mellitus	5.85e-05	0.039	CrCbGaD
Gliclazide—Glyburide—ABCC8—type 2 diabetes mellitus	5.76e-05	0.0383	CrCbGaD
Gliclazide—CYP2C9—liver—type 2 diabetes mellitus	5.54e-05	0.0112	CbGeAlD
Gliclazide—Glipizide—PPARG—type 2 diabetes mellitus	4.6e-05	0.0306	CrCbGaD
Gliclazide—Glyburide—KCNJ11—type 2 diabetes mellitus	4.06e-05	0.027	CrCbGaD
Gliclazide—Glyburide—ABCC2—type 2 diabetes mellitus	2.19e-05	0.0146	CrCbGaD
Gliclazide—Glipizide—CYP3A4—type 2 diabetes mellitus	1.99e-05	0.0132	CrCbGaD
Gliclazide—Malaise—Irbesartan—type 2 diabetes mellitus	1.15e-05	0.000205	CcSEcCtD
Gliclazide—Headache—Pioglitazone—type 2 diabetes mellitus	1.14e-05	0.000204	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	1.14e-05	0.000204	CcSEcCtD
Gliclazide—Leukopenia—Irbesartan—type 2 diabetes mellitus	1.14e-05	0.000204	CcSEcCtD
Gliclazide—Visual impairment—Ramipril—type 2 diabetes mellitus	1.14e-05	0.000203	CcSEcCtD
Gliclazide—Discomfort—Metformin—type 2 diabetes mellitus	1.14e-05	0.000203	CcSEcCtD
Gliclazide—Nausea—Glipizide—type 2 diabetes mellitus	1.13e-05	0.000202	CcSEcCtD
Gliclazide—Vomiting—Glimepiride—type 2 diabetes mellitus	1.13e-05	0.000202	CcSEcCtD
Gliclazide—Hypotension—Valsartan—type 2 diabetes mellitus	1.13e-05	0.000202	CcSEcCtD
Gliclazide—Vomiting—Sitagliptin—type 2 diabetes mellitus	1.13e-05	0.000201	CcSEcCtD
Gliclazide—Tremor—Losartan—type 2 diabetes mellitus	1.12e-05	0.000201	CcSEcCtD
Gliclazide—Rash—Glimepiride—type 2 diabetes mellitus	1.12e-05	0.0002	CcSEcCtD
Gliclazide—Dermatitis—Glimepiride—type 2 diabetes mellitus	1.12e-05	0.0002	CcSEcCtD
Gliclazide—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	1.12e-05	0.0002	CcSEcCtD
Gliclazide—Rash—Sitagliptin—type 2 diabetes mellitus	1.12e-05	0.0002	CcSEcCtD
Gliclazide—Dermatitis—Sitagliptin—type 2 diabetes mellitus	1.12e-05	0.0002	CcSEcCtD
Gliclazide—Erythema multiforme—Ramipril—type 2 diabetes mellitus	1.12e-05	0.0002	CcSEcCtD
Gliclazide—Headache—Glimepiride—type 2 diabetes mellitus	1.11e-05	0.000199	CcSEcCtD
Gliclazide—Ill-defined disorder—Losartan—type 2 diabetes mellitus	1.11e-05	0.000199	CcSEcCtD
Gliclazide—Cough—Irbesartan—type 2 diabetes mellitus	1.11e-05	0.000199	CcSEcCtD
Gliclazide—Headache—Sitagliptin—type 2 diabetes mellitus	1.11e-05	0.000198	CcSEcCtD
Gliclazide—Anaemia—Losartan—type 2 diabetes mellitus	1.11e-05	0.000198	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	1.1e-05	0.000197	CcSEcCtD
Gliclazide—Agitation—Losartan—type 2 diabetes mellitus	1.1e-05	0.000197	CcSEcCtD
Gliclazide—Tinnitus—Ramipril—type 2 diabetes mellitus	1.1e-05	0.000197	CcSEcCtD
Gliclazide—Hypertension—Irbesartan—type 2 diabetes mellitus	1.1e-05	0.000197	CcSEcCtD
Gliclazide—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	1.1e-05	0.000196	CcSEcCtD
Gliclazide—Flushing—Ramipril—type 2 diabetes mellitus	1.1e-05	0.000196	CcSEcCtD
Gliclazide—Angioedema—Losartan—type 2 diabetes mellitus	1.1e-05	0.000196	CcSEcCtD
Gliclazide—Infection—Metformin—type 2 diabetes mellitus	1.1e-05	0.000196	CcSEcCtD
Gliclazide—Insomnia—Valsartan—type 2 diabetes mellitus	1.1e-05	0.000196	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	1.09e-05	0.000195	CcSEcCtD
Gliclazide—Paraesthesia—Valsartan—type 2 diabetes mellitus	1.09e-05	0.000194	CcSEcCtD
Gliclazide—Chest pain—Irbesartan—type 2 diabetes mellitus	1.09e-05	0.000194	CcSEcCtD
Gliclazide—Arthralgia—Irbesartan—type 2 diabetes mellitus	1.09e-05	0.000194	CcSEcCtD
Gliclazide—Myalgia—Irbesartan—type 2 diabetes mellitus	1.09e-05	0.000194	CcSEcCtD
Gliclazide—Insomnia—Orlistat—type 2 diabetes mellitus	1.08e-05	0.000193	CcSEcCtD
Gliclazide—Malaise—Losartan—type 2 diabetes mellitus	1.08e-05	0.000193	CcSEcCtD
Gliclazide—Anxiety—Irbesartan—type 2 diabetes mellitus	1.08e-05	0.000193	CcSEcCtD
Gliclazide—Hypersensitivity—Glyburide—type 2 diabetes mellitus	1.08e-05	0.000193	CcSEcCtD
Gliclazide—Nervous system disorder—Metformin—type 2 diabetes mellitus	1.08e-05	0.000193	CcSEcCtD
Gliclazide—Thrombocytopenia—Metformin—type 2 diabetes mellitus	1.08e-05	0.000193	CcSEcCtD
Gliclazide—Dyspnoea—Valsartan—type 2 diabetes mellitus	1.08e-05	0.000193	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	1.08e-05	0.000192	CcSEcCtD
Gliclazide—Somnolence—Valsartan—type 2 diabetes mellitus	1.08e-05	0.000192	CcSEcCtD
Gliclazide—Paraesthesia—Orlistat—type 2 diabetes mellitus	1.07e-05	0.000192	CcSEcCtD
Gliclazide—Leukopenia—Losartan—type 2 diabetes mellitus	1.07e-05	0.000192	CcSEcCtD
Gliclazide—Discomfort—Irbesartan—type 2 diabetes mellitus	1.07e-05	0.000191	CcSEcCtD
Gliclazide—Skin disorder—Metformin—type 2 diabetes mellitus	1.07e-05	0.000191	CcSEcCtD
Gliclazide—Hyperhidrosis—Metformin—type 2 diabetes mellitus	1.07e-05	0.00019	CcSEcCtD
Gliclazide—Dyspepsia—Valsartan—type 2 diabetes mellitus	1.07e-05	0.00019	CcSEcCtD
Gliclazide—Dizziness—Bromocriptine—type 2 diabetes mellitus	1.06e-05	0.00019	CcSEcCtD
Gliclazide—Dry mouth—Irbesartan—type 2 diabetes mellitus	1.06e-05	0.00019	CcSEcCtD
Gliclazide—Palpitations—Losartan—type 2 diabetes mellitus	1.06e-05	0.000189	CcSEcCtD
Gliclazide—Nausea—Glimepiride—type 2 diabetes mellitus	1.06e-05	0.000189	CcSEcCtD
Gliclazide—Arrhythmia—Ramipril—type 2 diabetes mellitus	1.06e-05	0.000189	CcSEcCtD
Gliclazide—Loss of consciousness—Losartan—type 2 diabetes mellitus	1.05e-05	0.000188	CcSEcCtD
Gliclazide—Nausea—Sitagliptin—type 2 diabetes mellitus	1.05e-05	0.000188	CcSEcCtD
Gliclazide—Dyspepsia—Orlistat—type 2 diabetes mellitus	1.05e-05	0.000188	CcSEcCtD
Gliclazide—Asthenia—Glyburide—type 2 diabetes mellitus	1.05e-05	0.000188	CcSEcCtD
Gliclazide—Cough—Losartan—type 2 diabetes mellitus	1.05e-05	0.000187	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	1.05e-05	0.000187	CcSEcCtD
Gliclazide—Fatigue—Valsartan—type 2 diabetes mellitus	1.04e-05	0.000186	CcSEcCtD
Gliclazide—Pruritus—Glyburide—type 2 diabetes mellitus	1.04e-05	0.000185	CcSEcCtD
Gliclazide—Mental disorder—Ramipril—type 2 diabetes mellitus	1.04e-05	0.000185	CcSEcCtD
Gliclazide—Constipation—Valsartan—type 2 diabetes mellitus	1.04e-05	0.000185	CcSEcCtD
Gliclazide—Infection—Irbesartan—type 2 diabetes mellitus	1.03e-05	0.000185	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	1.03e-05	0.000184	CcSEcCtD
Gliclazide—Fatigue—Orlistat—type 2 diabetes mellitus	1.03e-05	0.000184	CcSEcCtD
Gliclazide—Hypotension—Metformin—type 2 diabetes mellitus	1.03e-05	0.000184	CcSEcCtD
Gliclazide—Erythema—Ramipril—type 2 diabetes mellitus	1.03e-05	0.000184	CcSEcCtD
Gliclazide—Malnutrition—Ramipril—type 2 diabetes mellitus	1.03e-05	0.000184	CcSEcCtD
Gliclazide—Pain—Orlistat—type 2 diabetes mellitus	1.02e-05	0.000183	CcSEcCtD
Gliclazide—Chest pain—Losartan—type 2 diabetes mellitus	1.02e-05	0.000182	CcSEcCtD
Gliclazide—Arthralgia—Losartan—type 2 diabetes mellitus	1.02e-05	0.000182	CcSEcCtD
Gliclazide—Myalgia—Losartan—type 2 diabetes mellitus	1.02e-05	0.000182	CcSEcCtD
Gliclazide—Vomiting—Bromocriptine—type 2 diabetes mellitus	1.02e-05	0.000182	CcSEcCtD
Gliclazide—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	1.02e-05	0.000182	CcSEcCtD
Gliclazide—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	1.02e-05	0.000182	CcSEcCtD
Gliclazide—Anxiety—Losartan—type 2 diabetes mellitus	1.02e-05	0.000182	CcSEcCtD
Gliclazide—Tachycardia—Irbesartan—type 2 diabetes mellitus	1.02e-05	0.000181	CcSEcCtD
Gliclazide—Rash—Bromocriptine—type 2 diabetes mellitus	1.01e-05	0.000181	CcSEcCtD
Gliclazide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	1.01e-05	0.000181	CcSEcCtD
Gliclazide—Skin disorder—Irbesartan—type 2 diabetes mellitus	1.01e-05	0.00018	CcSEcCtD
Gliclazide—Tension—Ramipril—type 2 diabetes mellitus	1.01e-05	0.00018	CcSEcCtD
Gliclazide—Discomfort—Losartan—type 2 diabetes mellitus	1.01e-05	0.00018	CcSEcCtD
Gliclazide—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	1.01e-05	0.00018	CcSEcCtD
Gliclazide—Headache—Bromocriptine—type 2 diabetes mellitus	1.01e-05	0.00018	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	1e-05	0.000179	CcSEcCtD
Gliclazide—Diarrhoea—Glyburide—type 2 diabetes mellitus	1e-05	0.000179	CcSEcCtD
Gliclazide—Nervousness—Ramipril—type 2 diabetes mellitus	9.99e-06	0.000178	CcSEcCtD
Gliclazide—Dry mouth—Losartan—type 2 diabetes mellitus	9.99e-06	0.000178	CcSEcCtD
Gliclazide—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	9.9e-06	0.000177	CcSEcCtD
Gliclazide—Paraesthesia—Metformin—type 2 diabetes mellitus	9.9e-06	0.000177	CcSEcCtD
Gliclazide—Confusional state—Losartan—type 2 diabetes mellitus	9.87e-06	0.000176	CcSEcCtD
Gliclazide—Feeling abnormal—Orlistat—type 2 diabetes mellitus	9.86e-06	0.000176	CcSEcCtD
Gliclazide—Dyspnoea—Metformin—type 2 diabetes mellitus	9.83e-06	0.000176	CcSEcCtD
Gliclazide—Somnolence—Metformin—type 2 diabetes mellitus	9.8e-06	0.000175	CcSEcCtD
Gliclazide—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	9.78e-06	0.000175	CcSEcCtD
Gliclazide—Infection—Losartan—type 2 diabetes mellitus	9.73e-06	0.000174	CcSEcCtD
Gliclazide—Hypotension—Irbesartan—type 2 diabetes mellitus	9.72e-06	0.000174	CcSEcCtD
Gliclazide—Dyspepsia—Metformin—type 2 diabetes mellitus	9.71e-06	0.000173	CcSEcCtD
Gliclazide—Glyburide—CYP3A4—type 2 diabetes mellitus	9.7e-06	0.00645	CrCbGaD
Gliclazide—Tremor—Ramipril—type 2 diabetes mellitus	9.64e-06	0.000172	CcSEcCtD
Gliclazide—Urticaria—Valsartan—type 2 diabetes mellitus	9.62e-06	0.000172	CcSEcCtD
Gliclazide—Nervous system disorder—Losartan—type 2 diabetes mellitus	9.6e-06	0.000171	CcSEcCtD
Gliclazide—Thrombocytopenia—Losartan—type 2 diabetes mellitus	9.59e-06	0.000171	CcSEcCtD
Gliclazide—Abdominal pain—Valsartan—type 2 diabetes mellitus	9.57e-06	0.000171	CcSEcCtD
Gliclazide—Tachycardia—Losartan—type 2 diabetes mellitus	9.56e-06	0.000171	CcSEcCtD
Gliclazide—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	9.55e-06	0.00017	CcSEcCtD
Gliclazide—Nausea—Bromocriptine—type 2 diabetes mellitus	9.54e-06	0.00017	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	9.52e-06	0.00017	CcSEcCtD
Gliclazide—Fatigue—Metformin—type 2 diabetes mellitus	9.51e-06	0.00017	CcSEcCtD
Gliclazide—Urticaria—Orlistat—type 2 diabetes mellitus	9.51e-06	0.00017	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	9.48e-06	0.000169	CcSEcCtD
Gliclazide—Hyperhidrosis—Losartan—type 2 diabetes mellitus	9.47e-06	0.000169	CcSEcCtD
Gliclazide—Abdominal pain—Orlistat—type 2 diabetes mellitus	9.46e-06	0.000169	CcSEcCtD
Gliclazide—Body temperature increased—Orlistat—type 2 diabetes mellitus	9.46e-06	0.000169	CcSEcCtD
Gliclazide—Agitation—Ramipril—type 2 diabetes mellitus	9.46e-06	0.000169	CcSEcCtD
Gliclazide—Constipation—Metformin—type 2 diabetes mellitus	9.43e-06	0.000168	CcSEcCtD
Gliclazide—Angioedema—Ramipril—type 2 diabetes mellitus	9.4e-06	0.000168	CcSEcCtD
Gliclazide—Paraesthesia—Irbesartan—type 2 diabetes mellitus	9.34e-06	0.000167	CcSEcCtD
Gliclazide—Vomiting—Glyburide—type 2 diabetes mellitus	9.33e-06	0.000167	CcSEcCtD
Gliclazide—Malaise—Ramipril—type 2 diabetes mellitus	9.28e-06	0.000166	CcSEcCtD
Gliclazide—Dyspnoea—Irbesartan—type 2 diabetes mellitus	9.28e-06	0.000166	CcSEcCtD
Gliclazide—Rash—Glyburide—type 2 diabetes mellitus	9.25e-06	0.000165	CcSEcCtD
Gliclazide—Somnolence—Irbesartan—type 2 diabetes mellitus	9.25e-06	0.000165	CcSEcCtD
Gliclazide—Dermatitis—Glyburide—type 2 diabetes mellitus	9.25e-06	0.000165	CcSEcCtD
Gliclazide—Leukopenia—Ramipril—type 2 diabetes mellitus	9.21e-06	0.000164	CcSEcCtD
Gliclazide—Headache—Glyburide—type 2 diabetes mellitus	9.2e-06	0.000164	CcSEcCtD
Gliclazide—Dyspepsia—Irbesartan—type 2 diabetes mellitus	9.16e-06	0.000164	CcSEcCtD
Gliclazide—Hypotension—Losartan—type 2 diabetes mellitus	9.15e-06	0.000163	CcSEcCtD
Gliclazide—Palpitations—Ramipril—type 2 diabetes mellitus	9.09e-06	0.000162	CcSEcCtD
Gliclazide—Feeling abnormal—Metformin—type 2 diabetes mellitus	9.09e-06	0.000162	CcSEcCtD
Gliclazide—Loss of consciousness—Ramipril—type 2 diabetes mellitus	9.04e-06	0.000161	CcSEcCtD
Gliclazide—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	9.02e-06	0.000161	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	8.98e-06	0.00016	CcSEcCtD
Gliclazide—Cough—Ramipril—type 2 diabetes mellitus	8.98e-06	0.00016	CcSEcCtD
Gliclazide—Fatigue—Irbesartan—type 2 diabetes mellitus	8.97e-06	0.00016	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	8.92e-06	0.000159	CcSEcCtD
Gliclazide—Hypersensitivity—Valsartan—type 2 diabetes mellitus	8.92e-06	0.000159	CcSEcCtD
Gliclazide—Convulsion—Ramipril—type 2 diabetes mellitus	8.91e-06	0.000159	CcSEcCtD
Gliclazide—Constipation—Irbesartan—type 2 diabetes mellitus	8.9e-06	0.000159	CcSEcCtD
Gliclazide—Pain—Irbesartan—type 2 diabetes mellitus	8.9e-06	0.000159	CcSEcCtD
Gliclazide—Insomnia—Losartan—type 2 diabetes mellitus	8.86e-06	0.000158	CcSEcCtD
Gliclazide—Hypersensitivity—Orlistat—type 2 diabetes mellitus	8.82e-06	0.000157	CcSEcCtD
Gliclazide—Paraesthesia—Losartan—type 2 diabetes mellitus	8.79e-06	0.000157	CcSEcCtD
Gliclazide—Urticaria—Metformin—type 2 diabetes mellitus	8.76e-06	0.000156	CcSEcCtD
Gliclazide—Arthralgia—Ramipril—type 2 diabetes mellitus	8.76e-06	0.000156	CcSEcCtD
Gliclazide—Chest pain—Ramipril—type 2 diabetes mellitus	8.76e-06	0.000156	CcSEcCtD
Gliclazide—Myalgia—Ramipril—type 2 diabetes mellitus	8.76e-06	0.000156	CcSEcCtD
Gliclazide—Dyspnoea—Losartan—type 2 diabetes mellitus	8.73e-06	0.000156	CcSEcCtD
Gliclazide—Anxiety—Ramipril—type 2 diabetes mellitus	8.73e-06	0.000156	CcSEcCtD
Gliclazide—Nausea—Glyburide—type 2 diabetes mellitus	8.72e-06	0.000156	CcSEcCtD
Gliclazide—Abdominal pain—Metformin—type 2 diabetes mellitus	8.72e-06	0.000156	CcSEcCtD
Gliclazide—Somnolence—Losartan—type 2 diabetes mellitus	8.71e-06	0.000155	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	8.7e-06	0.000155	CcSEcCtD
Gliclazide—Asthenia—Valsartan—type 2 diabetes mellitus	8.69e-06	0.000155	CcSEcCtD
Gliclazide—Discomfort—Ramipril—type 2 diabetes mellitus	8.65e-06	0.000155	CcSEcCtD
Gliclazide—Dyspepsia—Losartan—type 2 diabetes mellitus	8.62e-06	0.000154	CcSEcCtD
Gliclazide—Asthenia—Orlistat—type 2 diabetes mellitus	8.58e-06	0.000153	CcSEcCtD
Gliclazide—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	8.58e-06	0.000153	CcSEcCtD
Gliclazide—Pruritus—Valsartan—type 2 diabetes mellitus	8.57e-06	0.000153	CcSEcCtD
Gliclazide—Dry mouth—Ramipril—type 2 diabetes mellitus	8.57e-06	0.000153	CcSEcCtD
Gliclazide—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	8.51e-06	0.000152	CcSEcCtD
Gliclazide—Confusional state—Ramipril—type 2 diabetes mellitus	8.47e-06	0.000151	CcSEcCtD
Gliclazide—Pruritus—Orlistat—type 2 diabetes mellitus	8.47e-06	0.000151	CcSEcCtD
Gliclazide—Glyburide—ALB—type 2 diabetes mellitus	8.46e-06	0.00563	CrCbGaD
Gliclazide—Fatigue—Losartan—type 2 diabetes mellitus	8.44e-06	0.000151	CcSEcCtD
Gliclazide—Constipation—Losartan—type 2 diabetes mellitus	8.37e-06	0.00015	CcSEcCtD
Gliclazide—Pain—Losartan—type 2 diabetes mellitus	8.37e-06	0.00015	CcSEcCtD
Gliclazide—Diarrhoea—Valsartan—type 2 diabetes mellitus	8.29e-06	0.000148	CcSEcCtD
Gliclazide—Urticaria—Irbesartan—type 2 diabetes mellitus	8.27e-06	0.000148	CcSEcCtD
Gliclazide—Nervous system disorder—Ramipril—type 2 diabetes mellitus	8.24e-06	0.000147	CcSEcCtD
Gliclazide—Abdominal pain—Irbesartan—type 2 diabetes mellitus	8.23e-06	0.000147	CcSEcCtD
Gliclazide—Body temperature increased—Irbesartan—type 2 diabetes mellitus	8.23e-06	0.000147	CcSEcCtD
Gliclazide—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	8.22e-06	0.000147	CcSEcCtD
Gliclazide—Tachycardia—Ramipril—type 2 diabetes mellitus	8.2e-06	0.000146	CcSEcCtD
Gliclazide—Diarrhoea—Orlistat—type 2 diabetes mellitus	8.19e-06	0.000146	CcSEcCtD
Gliclazide—Skin disorder—Ramipril—type 2 diabetes mellitus	8.16e-06	0.000146	CcSEcCtD
Gliclazide—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	8.12e-06	0.000145	CcSEcCtD
Gliclazide—Feeling abnormal—Losartan—type 2 diabetes mellitus	8.07e-06	0.000144	CcSEcCtD
Gliclazide—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	8.01e-06	0.000143	CcSEcCtD
Gliclazide—Dizziness—Valsartan—type 2 diabetes mellitus	8.01e-06	0.000143	CcSEcCtD
Gliclazide—Dizziness—Orlistat—type 2 diabetes mellitus	7.91e-06	0.000141	CcSEcCtD
Gliclazide—Asthenia—Metformin—type 2 diabetes mellitus	7.91e-06	0.000141	CcSEcCtD
Gliclazide—Hypotension—Ramipril—type 2 diabetes mellitus	7.85e-06	0.00014	CcSEcCtD
Gliclazide—Pruritus—Metformin—type 2 diabetes mellitus	7.8e-06	0.000139	CcSEcCtD
Gliclazide—Urticaria—Losartan—type 2 diabetes mellitus	7.78e-06	0.000139	CcSEcCtD
Gliclazide—Body temperature increased—Losartan—type 2 diabetes mellitus	7.74e-06	0.000138	CcSEcCtD
Gliclazide—Abdominal pain—Losartan—type 2 diabetes mellitus	7.74e-06	0.000138	CcSEcCtD
Gliclazide—Vomiting—Valsartan—type 2 diabetes mellitus	7.7e-06	0.000137	CcSEcCtD
Gliclazide—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	7.67e-06	0.000137	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	7.65e-06	0.000137	CcSEcCtD
Gliclazide—Rash—Valsartan—type 2 diabetes mellitus	7.64e-06	0.000136	CcSEcCtD
Gliclazide—Dermatitis—Valsartan—type 2 diabetes mellitus	7.63e-06	0.000136	CcSEcCtD
Gliclazide—Vomiting—Orlistat—type 2 diabetes mellitus	7.61e-06	0.000136	CcSEcCtD
Gliclazide—Insomnia—Ramipril—type 2 diabetes mellitus	7.6e-06	0.000136	CcSEcCtD
Gliclazide—Headache—Valsartan—type 2 diabetes mellitus	7.59e-06	0.000135	CcSEcCtD
Gliclazide—Diarrhoea—Metformin—type 2 diabetes mellitus	7.54e-06	0.000135	CcSEcCtD
Gliclazide—Rash—Orlistat—type 2 diabetes mellitus	7.54e-06	0.000135	CcSEcCtD
Gliclazide—Paraesthesia—Ramipril—type 2 diabetes mellitus	7.54e-06	0.000135	CcSEcCtD
Gliclazide—Dermatitis—Orlistat—type 2 diabetes mellitus	7.54e-06	0.000135	CcSEcCtD
Gliclazide—Headache—Orlistat—type 2 diabetes mellitus	7.5e-06	0.000134	CcSEcCtD
Gliclazide—Dyspnoea—Ramipril—type 2 diabetes mellitus	7.49e-06	0.000134	CcSEcCtD
Gliclazide—Asthenia—Irbesartan—type 2 diabetes mellitus	7.47e-06	0.000133	CcSEcCtD
Gliclazide—Somnolence—Ramipril—type 2 diabetes mellitus	7.47e-06	0.000133	CcSEcCtD
Gliclazide—Dyspepsia—Ramipril—type 2 diabetes mellitus	7.39e-06	0.000132	CcSEcCtD
Gliclazide—Pruritus—Irbesartan—type 2 diabetes mellitus	7.36e-06	0.000131	CcSEcCtD
Gliclazide—Dizziness—Metformin—type 2 diabetes mellitus	7.29e-06	0.00013	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	7.25e-06	0.000129	CcSEcCtD
Gliclazide—Fatigue—Ramipril—type 2 diabetes mellitus	7.24e-06	0.000129	CcSEcCtD
Gliclazide—Hypersensitivity—Losartan—type 2 diabetes mellitus	7.22e-06	0.000129	CcSEcCtD
Gliclazide—Nausea—Valsartan—type 2 diabetes mellitus	7.19e-06	0.000128	CcSEcCtD
Gliclazide—Constipation—Ramipril—type 2 diabetes mellitus	7.18e-06	0.000128	CcSEcCtD
Gliclazide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	7.12e-06	0.000127	CcSEcCtD
Gliclazide—Nausea—Orlistat—type 2 diabetes mellitus	7.11e-06	0.000127	CcSEcCtD
Gliclazide—Asthenia—Losartan—type 2 diabetes mellitus	7.03e-06	0.000125	CcSEcCtD
Gliclazide—Vomiting—Metformin—type 2 diabetes mellitus	7.01e-06	0.000125	CcSEcCtD
Gliclazide—Rash—Metformin—type 2 diabetes mellitus	6.95e-06	0.000124	CcSEcCtD
Gliclazide—Dermatitis—Metformin—type 2 diabetes mellitus	6.95e-06	0.000124	CcSEcCtD
Gliclazide—Pruritus—Losartan—type 2 diabetes mellitus	6.93e-06	0.000124	CcSEcCtD
Gliclazide—Feeling abnormal—Ramipril—type 2 diabetes mellitus	6.92e-06	0.000124	CcSEcCtD
Gliclazide—Headache—Metformin—type 2 diabetes mellitus	6.91e-06	0.000123	CcSEcCtD
Gliclazide—Dizziness—Irbesartan—type 2 diabetes mellitus	6.88e-06	0.000123	CcSEcCtD
Gliclazide—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	6.87e-06	0.000123	CcSEcCtD
Gliclazide—Diarrhoea—Losartan—type 2 diabetes mellitus	6.7e-06	0.00012	CcSEcCtD
Gliclazide—Urticaria—Ramipril—type 2 diabetes mellitus	6.67e-06	0.000119	CcSEcCtD
Gliclazide—Body temperature increased—Ramipril—type 2 diabetes mellitus	6.64e-06	0.000119	CcSEcCtD
Gliclazide—Abdominal pain—Ramipril—type 2 diabetes mellitus	6.64e-06	0.000119	CcSEcCtD
Gliclazide—Vomiting—Irbesartan—type 2 diabetes mellitus	6.62e-06	0.000118	CcSEcCtD
Gliclazide—Rash—Irbesartan—type 2 diabetes mellitus	6.56e-06	0.000117	CcSEcCtD
Gliclazide—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.56e-06	0.000117	CcSEcCtD
Gliclazide—Nausea—Metformin—type 2 diabetes mellitus	6.55e-06	0.000117	CcSEcCtD
Gliclazide—Headache—Irbesartan—type 2 diabetes mellitus	6.52e-06	0.000116	CcSEcCtD
Gliclazide—Dizziness—Losartan—type 2 diabetes mellitus	6.48e-06	0.000116	CcSEcCtD
Gliclazide—Vomiting—Losartan—type 2 diabetes mellitus	6.23e-06	0.000111	CcSEcCtD
Gliclazide—Hypersensitivity—Ramipril—type 2 diabetes mellitus	6.19e-06	0.00011	CcSEcCtD
Gliclazide—Nausea—Irbesartan—type 2 diabetes mellitus	6.18e-06	0.00011	CcSEcCtD
Gliclazide—Rash—Losartan—type 2 diabetes mellitus	6.17e-06	0.00011	CcSEcCtD
Gliclazide—Dermatitis—Losartan—type 2 diabetes mellitus	6.17e-06	0.00011	CcSEcCtD
Gliclazide—Headache—Losartan—type 2 diabetes mellitus	6.14e-06	0.00011	CcSEcCtD
Gliclazide—Asthenia—Ramipril—type 2 diabetes mellitus	6.02e-06	0.000108	CcSEcCtD
Gliclazide—Pruritus—Ramipril—type 2 diabetes mellitus	5.94e-06	0.000106	CcSEcCtD
Gliclazide—Nausea—Losartan—type 2 diabetes mellitus	5.82e-06	0.000104	CcSEcCtD
Gliclazide—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.75e-06	0.000103	CcSEcCtD
Gliclazide—Dizziness—Ramipril—type 2 diabetes mellitus	5.55e-06	9.91e-05	CcSEcCtD
Gliclazide—Vomiting—Ramipril—type 2 diabetes mellitus	5.34e-06	9.53e-05	CcSEcCtD
Gliclazide—Rash—Ramipril—type 2 diabetes mellitus	5.29e-06	9.45e-05	CcSEcCtD
Gliclazide—Dermatitis—Ramipril—type 2 diabetes mellitus	5.29e-06	9.44e-05	CcSEcCtD
Gliclazide—Headache—Ramipril—type 2 diabetes mellitus	5.26e-06	9.39e-05	CcSEcCtD
Gliclazide—Nausea—Ramipril—type 2 diabetes mellitus	4.99e-06	8.91e-05	CcSEcCtD
Gliclazide—ALB—Hemostasis—CALM1—type 2 diabetes mellitus	2.02e-06	7.68e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—KCNJ11—type 2 diabetes mellitus	2.01e-06	7.63e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GCKR—type 2 diabetes mellitus	2.01e-06	7.63e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—LPA—type 2 diabetes mellitus	2.01e-06	7.63e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—HSD3B2—type 2 diabetes mellitus	2.01e-06	7.63e-05	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—AKT1—type 2 diabetes mellitus	2e-06	7.61e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—COX2—type 2 diabetes mellitus	2e-06	7.61e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—SLC5A2—type 2 diabetes mellitus	2e-06	7.61e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PCK1—type 2 diabetes mellitus	1.99e-06	7.58e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—APOA1—type 2 diabetes mellitus	1.99e-06	7.56e-05	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—ALB—type 2 diabetes mellitus	1.98e-06	7.53e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.98e-06	7.53e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.98e-06	7.51e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—AGT—type 2 diabetes mellitus	1.97e-06	7.5e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—NCOA6—type 2 diabetes mellitus	1.97e-06	7.47e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.97e-06	7.47e-05	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—AKT1—type 2 diabetes mellitus	1.97e-06	7.46e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.96e-06	7.46e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.94e-06	7.37e-05	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—TGFB1—type 2 diabetes mellitus	1.94e-06	7.35e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—APOE—type 2 diabetes mellitus	1.94e-06	7.35e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—LEP—type 2 diabetes mellitus	1.94e-06	7.35e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—UCP3—type 2 diabetes mellitus	1.93e-06	7.35e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—HSD11B1—type 2 diabetes mellitus	1.93e-06	7.35e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—UCP2—type 2 diabetes mellitus	1.93e-06	7.35e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.93e-06	7.34e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ALDOB—type 2 diabetes mellitus	1.93e-06	7.32e-05	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—ALB—type 2 diabetes mellitus	1.92e-06	7.3e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.92e-06	7.28e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.91e-06	7.26e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—PRKCB—type 2 diabetes mellitus	1.9e-06	7.21e-05	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PIK3R1—type 2 diabetes mellitus	1.9e-06	7.21e-05	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—NOS3—type 2 diabetes mellitus	1.9e-06	7.21e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—NOS2—type 2 diabetes mellitus	1.88e-06	7.13e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.88e-06	7.12e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.87e-06	7.11e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—HK1—type 2 diabetes mellitus	1.87e-06	7.09e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.87e-06	7.09e-05	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PIK3R1—type 2 diabetes mellitus	1.84e-06	6.99e-05	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—NOS3—type 2 diabetes mellitus	1.84e-06	6.99e-05	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.84e-06	6.98e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.83e-06	6.96e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.82e-06	6.93e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PCK1—type 2 diabetes mellitus	1.82e-06	6.91e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.81e-06	6.88e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GCKR—type 2 diabetes mellitus	1.8e-06	6.85e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—HSD3B2—type 2 diabetes mellitus	1.8e-06	6.85e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—LPA—type 2 diabetes mellitus	1.8e-06	6.85e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—KCNJ11—type 2 diabetes mellitus	1.8e-06	6.85e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GLP1R—type 2 diabetes mellitus	1.79e-06	6.8e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.79e-06	6.8e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.75e-06	6.63e-05	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PTGS2—type 2 diabetes mellitus	1.74e-06	6.59e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.73e-06	6.59e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ALDOB—type 2 diabetes mellitus	1.73e-06	6.57e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.73e-06	6.55e-05	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.72e-06	6.55e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	1.7e-06	6.47e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.7e-06	6.46e-05	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PTGS2—type 2 diabetes mellitus	1.68e-06	6.39e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.68e-06	6.38e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—SLC2A2—type 2 diabetes mellitus	1.67e-06	6.35e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—IGF1—type 2 diabetes mellitus	1.66e-06	6.32e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—AKT2—type 2 diabetes mellitus	1.66e-06	6.32e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—INS—type 2 diabetes mellitus	1.65e-06	6.28e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.65e-06	6.25e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	1.65e-06	6.25e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	1.65e-06	6.25e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	1.65e-06	6.25e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	1.65e-06	6.25e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—MTR—type 2 diabetes mellitus	1.64e-06	6.22e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CPT1A—type 2 diabetes mellitus	1.64e-06	6.22e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.63e-06	6.18e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.63e-06	6.18e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GLP1R—type 2 diabetes mellitus	1.61e-06	6.11e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—NAMPT—type 2 diabetes mellitus	1.61e-06	6.1e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.6e-06	6.07e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.6e-06	6.07e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.6e-06	6.07e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—LIPC—type 2 diabetes mellitus	1.6e-06	6.06e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—HBA1—type 2 diabetes mellitus	1.6e-06	6.06e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GCK—type 2 diabetes mellitus	1.6e-06	6.06e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CYP11A1—type 2 diabetes mellitus	1.59e-06	6.03e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.58e-06	6.01e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—SERPINE1—type 2 diabetes mellitus	1.58e-06	6e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	1.58e-06	5.99e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—SLC9A1—type 2 diabetes mellitus	1.56e-06	5.92e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CETP—type 2 diabetes mellitus	1.54e-06	5.85e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.53e-06	5.82e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.52e-06	5.77e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—PIK3R1—type 2 diabetes mellitus	1.51e-06	5.73e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—NOS3—type 2 diabetes mellitus	1.51e-06	5.73e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—SLC2A2—type 2 diabetes mellitus	1.5e-06	5.7e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.5e-06	5.7e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.48e-06	5.63e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CPT1A—type 2 diabetes mellitus	1.47e-06	5.58e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—MTR—type 2 diabetes mellitus	1.47e-06	5.58e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	1.47e-06	5.57e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.45e-06	5.5e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.45e-06	5.5e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—NAMPT—type 2 diabetes mellitus	1.44e-06	5.48e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.43e-06	5.44e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GCK—type 2 diabetes mellitus	1.43e-06	5.44e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—LIPC—type 2 diabetes mellitus	1.43e-06	5.44e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—HBA1—type 2 diabetes mellitus	1.43e-06	5.44e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PSMD6—type 2 diabetes mellitus	1.43e-06	5.44e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—SNAP25—type 2 diabetes mellitus	1.43e-06	5.44e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—SREBF1—type 2 diabetes mellitus	1.43e-06	5.44e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CYP11A1—type 2 diabetes mellitus	1.42e-06	5.41e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CTGF—type 2 diabetes mellitus	1.41e-06	5.34e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—SLC9A1—type 2 diabetes mellitus	1.4e-06	5.31e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—HMGCR—type 2 diabetes mellitus	1.39e-06	5.29e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CETP—type 2 diabetes mellitus	1.38e-06	5.25e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.37e-06	5.22e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	1.37e-06	5.2e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—RELA—type 2 diabetes mellitus	1.36e-06	5.18e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ADRA2A—type 2 diabetes mellitus	1.36e-06	5.18e-05	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	1.35e-06	5.11e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	1.34e-06	5.09e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	1.34e-06	5.09e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	1.32e-06	4.99e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	1.31e-06	4.97e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.31e-06	4.96e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	1.31e-06	4.96e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	1.31e-06	4.96e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	1.31e-06	4.96e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	1.3e-06	4.93e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	1.3e-06	4.92e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	1.3e-06	4.92e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.29e-06	4.9e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	1.29e-06	4.88e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	1.29e-06	4.88e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	1.29e-06	4.88e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	1.28e-06	4.84e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	1.26e-06	4.8e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	1.26e-06	4.79e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	1.26e-06	4.79e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.26e-06	4.77e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	1.25e-06	4.75e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	1.24e-06	4.71e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GCG—type 2 diabetes mellitus	1.24e-06	4.71e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.23e-06	4.68e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.23e-06	4.67e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	1.22e-06	4.65e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	1.18e-06	4.46e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.18e-06	4.46e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	1.17e-06	4.45e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	1.17e-06	4.45e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	1.17e-06	4.45e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.16e-06	4.42e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	1.16e-06	4.41e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	1.16e-06	4.41e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.15e-06	4.37e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	1.15e-06	4.37e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	1.14e-06	4.33e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	1.13e-06	4.31e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.13e-06	4.28e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.12e-06	4.27e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—SRC—type 2 diabetes mellitus	1.12e-06	4.24e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	1.12e-06	4.24e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	1.11e-06	4.23e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	1.11e-06	4.23e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	1.09e-06	4.13e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—SRC—type 2 diabetes mellitus	1.07e-06	4.07e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	1.07e-06	4.07e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.07e-06	4.06e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GNB3—type 2 diabetes mellitus	1.07e-06	4.06e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	1.07e-06	4.05e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	1.06e-06	4.03e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	1.06e-06	4.03e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CAT—type 2 diabetes mellitus	1.05e-06	3.99e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	1.03e-06	3.93e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.03e-06	3.91e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—APOB—type 2 diabetes mellitus	1.02e-06	3.87e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	1.02e-06	3.86e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	1.02e-06	3.86e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	9.98e-07	3.79e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	9.93e-07	3.77e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—LPL—type 2 diabetes mellitus	9.74e-07	3.7e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.61e-07	3.65e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	9.61e-07	3.65e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.59e-07	3.64e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	9.56e-07	3.63e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	9.54e-07	3.62e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GPX1—type 2 diabetes mellitus	9.51e-07	3.61e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	9.44e-07	3.58e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.4e-07	3.57e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CD36—type 2 diabetes mellitus	9.26e-07	3.52e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	9.16e-07	3.48e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	9.14e-07	3.47e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	8.91e-07	3.38e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	8.77e-07	3.33e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	8.76e-07	3.33e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.76e-07	3.33e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	8.75e-07	3.32e-05	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—AKT1—type 2 diabetes mellitus	8.72e-07	3.31e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	8.72e-07	3.31e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PPARA—type 2 diabetes mellitus	8.61e-07	3.27e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	8.6e-07	3.27e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	8.56e-07	3.25e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	8.53e-07	3.24e-05	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—AKT1—type 2 diabetes mellitus	8.46e-07	3.21e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	8.35e-07	3.17e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—AGT—type 2 diabetes mellitus	8.34e-07	3.17e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	8.31e-07	3.16e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	8.21e-07	3.12e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CALM1—type 2 diabetes mellitus	8.2e-07	3.11e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—APOE—type 2 diabetes mellitus	8.17e-07	3.1e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	8.12e-07	3.09e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—APOA1—type 2 diabetes mellitus	8.07e-07	3.07e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	7.97e-07	3.03e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	7.87e-07	2.99e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	7.81e-07	2.96e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	7.78e-07	2.95e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	7.73e-07	2.93e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	7.58e-07	2.88e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	7.48e-07	2.84e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	7.48e-07	2.84e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	7.36e-07	2.79e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	7.33e-07	2.78e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	7.25e-07	2.75e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IL6—type 2 diabetes mellitus	7.22e-07	2.74e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	7.18e-07	2.73e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PPARG—type 2 diabetes mellitus	7.11e-07	2.7e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	7.04e-07	2.67e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—INS—type 2 diabetes mellitus	6.98e-07	2.65e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	6.94e-07	2.63e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	6.82e-07	2.59e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	6.71e-07	2.55e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	6.68e-07	2.54e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.66e-07	2.53e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	6.61e-07	2.51e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	6.39e-07	2.42e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	6.26e-07	2.38e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—NOS3—type 2 diabetes mellitus	6.12e-07	2.32e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	6.12e-07	2.32e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	5.82e-07	2.21e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	5.74e-07	2.18e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	5.71e-07	2.17e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	5.6e-07	2.12e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	5.49e-07	2.09e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	5.49e-07	2.09e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	5.24e-07	1.99e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	5.02e-07	1.91e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	5.01e-07	1.9e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	5.01e-07	1.9e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	4.58e-07	1.74e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—AKT1—type 2 diabetes mellitus	2.81e-07	1.07e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	2.52e-07	9.59e-06	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	2.3e-07	8.74e-06	CbGpPWpGaD
